Abstract
To assess the height percentile (HP) change ofPanax Ginseng (PG) included herbal complex(PGhc) prescribed children with any symptom inprimary care clinics, a retrospective analysis fromJanuary 2004 till December 2009 was performed at1st visit between 3 and 12-year-old who had 2ndvisit at least 6 months later. Height was measuredat every visit and the HP was calculated with KoreaCenters for Disease and Prevention Growth Chart. Grouping with Extremely Low height (0-3%, ELH), Very Low height (3-10%, VLH), Low height (10-25%, LH), Average Low height (25-50%, ALH), Average high height (50-75%, AHH), High height(75-90%, HH), Very High height (90-97%, VHH) andExtremely High height (97-100%, EHH) based on1st visit measures, 37,047 children were included. The number of children and PGhc administrationperiod (days) are listed below; ELH-1,918-43.8, VLH-4,936-39.6, LH-8,606-37.7, ALH-10,500-35.1, AHH-6,932-33.2, HH-2,923-32.0, VHH-935-28.9and EHH-297-29.9. The HP change of ELH is +1.8±8.5 (p< 0.0001), VLH is +2.0± 10.7 (p< 0.0001), LHis +2.0± 11.9 (p< 0.0001), ALH is +2.0± 11.5 (p<0.0001), AHH is +1.7± 11.5 (p< 0.0001), HH is +1.0±11.3 (p=0.2514), VHH is +0.2± 10.5 (p=0.3440), EHH is -2.7± 16.4 (p< 0.0001). In the prescribedchildren under average height (ELH, VLH, LH andALH), regardless of their symptoms, it significantlyintends to promote height growth as well as AHH. This result suggests that PGhc may influence onthe physical height upward. Further studies areneeded whether Panax Ginseng has the effect ofchange the hormonal status among children undergrowing.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have